The global extracorporeal membrane oxygenation (ECMO) system market accounted for USD 227.7 million in 2014 and is expected to reach USD 287.6 million by 2020 at a CAGR of 4.0% from 2015 to 2020.

The purpose of this report is to cover the definition, description, and forecast of Global Extracorporeal Membrane Oxygenation (ECMO) System market. It involves deep dive analysis of market segmentation which comprises of submarkets, modality and application. The report also offers strategic analysis of key players in the market. In this report, the Extracorporeal Membrane Oxygenation (ECMO) System market is segmented on the basis of its modality and application. In terms of modality, the market is segmented into Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).

This market has been segmented by application, which includes Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). There spiratory segment was the largest application of the global Extracorporeal Membrane Oxygenation (ECMO) System market in 2014.

Globally, North America contributed to the largest Extracorporeal Membrane Oxygenation (ECMO) System market in 2014.The large share is attributed to rise in the increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancements in ECMO system, success rate of ECMO and government initiatives and growing awareness towards ECMO. All these factors would help improve the demand of ECMO machines, which are used on a small scale in hospitals currently.

Further more, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market. Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome. More than 5 million patients are admitted annually to ICUs in the U.S.

In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 percent of all deaths in the U.S. However, cost of high end equipment, presence of conventional techniques, risk of complications, renal failure associated with ECMO are some of the restraints for the Extracorporeal Membrane Oxygenation (ECMO) System market.

The report also provides a detailed competitive landscaping of companies operating in this market. It also offers segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of major companies. The main companies operating in this market are MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Also, the report covers basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the Extra corporeal Membrane Oxygenation (ECMO) System market.

The report offers detailed information on new entrants/smaller firms to gauge the pulse of the market, which in turn helps garner the market share. The firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:

• Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the market.
• Market Development: Offers comprehensive information about lucrative emerging markets. Analysis of market across various regions; distribution channels, clientele base and pricing policies involved vis-à-vis geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions. Detailed description regarding the related and unrelated diversification pertaining to the market.
• Competitive Assessment: An in-depth assessment of market shares and company share analyses of the key players projected till 2020. Business strategies and manufacturing capabilities of leading players are also provided.

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders

2 Research Methodology
2.1 Integrated Ecosystem of the Market
2.2 Arriving at the Market Size
2.2.1 Top-Down Approach
2.2.2 Macro Indicator- Based Approach
2.3 Price Analysis of Extra Corporeal Membrane Oxygenation Systems Market, By Product
2.4 Assumptions

3 Executive Summary

4 Market Overview
4.1 Market Drivers and Inhibitors
4.2 Threats of Ecmo
4.3 Opportunities in Future

5 Extracorporeal Membrane Oxygenation Systems Market, By Modality
5.1 Introduction
5.2 Veno-Arterial
5.3 Veno-Venous
5.4 Arterio-Venous (AV)

6 Extracorporeal Membrane Oxygenation Systems Market, By Application
6.1 Introduction
6.2 Respiratory
6.2.1 Neonates
6.2.2 Pediatric
6.2.3 Adult
6.3 Cardiac
6.3.1 Neonates
6.3.2 Pediatric
6.3.3 Adult
6.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.4.1 Neonates
6.4.2 Pediatric
6.4.3 Adult

7 Extracorporeal Membrane Oxygenation Systems Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Switzerland
7.3.7 Rest of Europe (RoE)
7.4 Asia-Pacific (APAC)
7.4.1 Japan
7.4.2 Australia
7.4.3 China
7.4.4 India
7.4.5 Singapore
7.4.6 Republic of Korea
7.4.7 Rest of Asia-Pacific
7.5 Rest of the World (RoW)

8 Competitive Landscape
8.1.1 New Product Launch & Product Development
8.1.2 Agreement, Acquisition & Partnership
8.1.3 Expansion
8.1.4 Other

9 Company Profiles
9.1 Maquet Holding B.V. & Co. Kg.
9.1.1 Overview
9.1.2 Key Financials
9.1.3 Product and Service Offerings
9.1.4 Related Developments
9.1.5 MnM View
9.2 Medtronic, Inc. (U.S.)
9.2.1 Overview
9.2.2 Key Financials
9.2.3 Product and Service Offerings
9.2.4 Related Developments
9.2.5 MnM View
9.3 Microport Scientific Corporation
9.3.1 Overview
9.3.2 Key Financials
9.3.3 Product and Service Offerings
9.3.4 MnM View
9.4 Terumo Cardiovascular Systems Corporation
9.4.1 Overview
9.4.2 Key Financials
9.4.3 Product and Service Offerings
9.4.4 Related Developments
9.4.5 MnM View
9.5 Medos Medizintechnik AG
9.5.1 Overview
9.5.2 Product and Service Offerings
9.5.3 Related Developments
9.5.4 MnM View
9.6 Nipro Medical Corporation
9.6.1 Overview
9.6.2 Key Financials
9.6.3 Product and Service Offerings
9.6.4 Related Developments
9.6.5 MnM View
9.7 Sorin Group (Sorin S.P.A.)
9.7.1 Overview
9.7.2 Sorin Group: Key Financials
9.7.3 Product and Service Offerings
9.7.4 Related Developments
9.7.5 MnM View

10 Appendix
10.1 Introducing Rt: Real-Time Market Intelligence
10.2 Customization Options
10.2.1 Product Analysis
10.2.2 Pulmonologist/Physicians Perception Analysis
10.2.3 Regulatory Framework
10.2.4 Competitive Intelligence
10.3 Related Reports

List of Tables

Table 1 Extracorporeal Membrane Oxygenation Systems Market: Macro Indicators, By Country, 2014 (USD Million)
Table 2 Market: Drivers and Inhibitors
Table 3 Extracorporeal Membrane Oxygenation (ECMO) Market, By Modality, 2013-2020 (USD Million)
Table 4 Veno-Arterial Market, By Geography, 2013–2020 (USD Million)
Table 5 Veno-Venous Market, By Geography, 2013–2020 (USD Million)
Table 6 Arterio-Venous Extracorporeal Membrane Oxygenation Market, By Geography, 2013–2020 (USD Million)
Table 7 Market, By Application, 2013-2020 (USD Million)
Table 8 Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 9 Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 10 Market in ECPR, By Age Group, 2013-2020 (USD Million)
Table 11 Market, By Geography, 2013-2020 (USD Million)
Table 12 North America: Market, By Modality, 2013-2020 (USD Million)
Table 13 North America: Market, By Application, 2013-2020 (USD Million)
Table 14 North America: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 15 North America: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 16 North America: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 17 U.S.: Market, By Modality, 2013-2020 (USD Million)
Table 18 U.S.: Extra Corporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 19 Canada: Market, By Modality, 2013-2020 (USD Million)
Table 20 Canada: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 21 Mexico: Market, By Modality, 2013-2020 (USD Million)
Table 22 Mexico: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 23 Europe: Market, By Modality, 2013-2020 (USD Million)
Table 24 Europe: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 25 Europe: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 26 Europe: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 27 Europe: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 28 Germany: Market, By Modality, 2013-2020 (USD Million)
Table 29 Germany: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 30 U.K.: Market, By Modality, 2013-2020 (USD Million)
Table 31 U.K.: Market, By Application, 2013-2020 (USD Million)
Table 32 France: Market, By Modality, 2013-2020 (USD Million)
Table 33 France: Market, By Application, 2013-2020 (USD Million)
Table 34 Italy: Market, By Modality, 2013-2020 (USD Million)
Table 35 Italy: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 36 Spain: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 37 Spain: Market, By Application, 2013-2020 (USD Million)
Table 38 Switzerland: Market, By Modality, 2013-2020 (USD Million)
Table 39 Switzerland: Market, By Application, 2013-2020 (USD Million)
Table 40 RoE: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 41 RoE: Market, By Application, 2013-2020 (USD Million)
Table 42 APAC: Market, By Modality, 2013-2020 (USD Million)
Table 43 APAC: Market, By Application, 2013-2020 (USD Million)
Table 44 APAC: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 45 APAC: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 46 APAC: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 47 Japan: Market, By Modality, 2013-2020 (USD Million)
Table 48 Japan: Market, By Application, 2013-2020 (USD Million)
Table 49 Australia: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 50 Australia: Extra Corporeal Membrane Oxygenation Systems Market, By Application, 2013-2020 (USD Million)
Table 51 China: Market, By Modality, 2013-2020 (USD Million)
Table 52 China: Market, By Application, 2013-2020 (USD Million)
Table 53 India: Market, By Modality, 2013-2020 (USD Million)
Table 54 India: Extra Corporeal Membrane Oxygenation Systems Market, By Application, 2013-2020 (USD Million)
Table 55 Singapore: Market, By Modality, 2013-2020 (USD Million)
Table 56 Singapore: Market, By Application, 2013-2020 (USD Million)
Table 57 Republic of Korea: Market, By Modality, 2013-2020 (USD Million)
Table 58 Republic of Korea: Market, By Application, 2013-2020 (USD Million)
Table 59 Rest of APAC: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 60 Rest of APAC: Market, By Application, 2013-2020 (USD Million)
Table 61 RoW: Market, By Modality, 2013-2020 (USD Million)
Table 62 RoW: Market, By Application, 2013-2020 (USD Million)
Table 63 RoW: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 64 RoW: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 65 RoW: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 66 Extra Corporeal Membrane Oxygenation System Market, By Company, 2014 (%)
Table 67 Maquet Holding B.V. & Co. Kg.: Key Financials, By Business Segment, 2012-2014 (USD MN)
Table 68 Maquet Holding B.V. & Co. Kg.: Key Financials, By Geography,2012-2014 (USD MN)
Table 69 Medtronic, Inc. : Key Financials, By Business Segment,2012-2014 (USD MN)
Table 70 Medtronic, Inc.: Key Financials, By Geography, 2012-2014 (USD MN)
Table 71 Microport Scientific Corporation: Key Financials, By Business Segment, 2012-2014 (USD MN)
Table 72 Microport Scientific Corporation: Key Financials, By Geography,2012-2014 (USD MN)
Table 73 Terumo Cardiovascular Systems Corporation: Key Financials, By Business Segment, 2012-2014 (USD MN)
Table 74 Terumo Cardiovascular Systems Corporation: Key Financials, By Geography, 2012-2014 (USD MN)
Table 75 Nipro Medical Corporation: Key Financials, By Business Segment,2011-2014 (USD MN)
Table 76 Sorin Group: Key Financials, By Business Segment, 2013-2014 (USD MN)
Table 77 Sorin Group: Key Financials (Cardiac Surgery), By Business Sub-Segment, 2013-2014 (USD MN)
Table 78 Sorin Group: Key Financials, By Geography, 2013-2014 (USD MN)

List of Figures

Figure 1 Extracorporeal Membrane Oxygenation Systems Market Segmentation & Coverage
Figure 2 Market: Integrated Ecosystem
Figure 3 Arriving at the Market Size
Figure 4 Top-Down Approach
Figure 5 Macro Indicator-Based Approach
Figure 6 Market Snapshot
Figure 7 Extracorporeal Membrane Oxygenation Market, By Modality,2014 & 2020 (USD Million)
Figure 8 Veno-Arterial Extracorporeal Membrane Oxygenation Systems Market, By Geography, 2015 & 2020 (USD Million)
Figure 9 Veno-Venous Extracorporeal Membrane Oxygenation Systems Market, By Geography, 2015 & 2020 (USD Million)
Figure 10 Arterio-Venous Extracorporeal Membrane Oxygenation Market, By Geography, 2015 & 2020 (USD Million)
Figure 11 Indications Where ECMO is Used
Figure 12 Market, By Application, 2014 & 2020 (USD Million)
Figure 13 Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 14 Neonatal Survival Rate, Extracorporeal Life Support Organization (ELSO) Data (1987-1993)
Figure 15 Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 16 Market in ECPR, By Age Group, 2015 & 2020 (USD Million)
Figure 17 Extra Corporeal Membrane Oxygenation (ECMO): Growth Analysis, By Geography, 2014-2020 (USD Million)
Figure 18 North America: Market Overview, 2014 & 2020 (%)
Figure 19 North America: Market in Respiratory Application, By Age Group,2015 & 2020 (USD Million)
Figure 20 North America: Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 21 North America: Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 22 U.S.: Market Overview, 2014 & 2020 (%)
Figure 23 U.S.: Market, By Modality, 2015 & 2020 (USD Million)
Figure 24 U.S.: Market, By Application, 2015 & 2020 (USD Million)
Figure 25 Canada: Market Overview, 2014 & 2020 (%)
Figure 26 Canada: Market, By Modality, 2015 & 2020 (USD Million)
Figure 27 Canada: Market, By Application, 2015 & 2020 (USD Million)
Figure 28 Mexico: Market Overview, 2014 & 2020 (%)
Figure 29 Mexico: Market, By Modality, 2015 & 2020 (USD Million)
Figure 30 Mexico: Market, By Application, 2015 & 2020 (USD Million)
Figure 31 Europe: Market Overview, 2014 & 2020 (%)
Figure 32 Europe: Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 33 Europe: Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 34 Europe: Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 35 Germany: Market Overview, 2014 & 2020 (%)
Figure 36 Germany: Market, By Modality, 2015 & 2020 (USD Million)
Figure 37 Germany: Market, By Application, 2015 & 2020 (USD Million)
Figure 38 U.K.: Market Overview, 2014 & 2020 (%)
Figure 39 U.K.: Market, By Modality, 2015 & 2020 (USD Million)
Figure 40 U.K.: Market, By Application, 2015 & 2020 (USD Million)
Figure 41 France: Market Overview, 2014 & 2020 (%)
Figure 42 France: Market, By Modality, 2015 & 2020 (USD Million)
Figure 43 France: Market, By Application, 2015 & 2020 (USD Million)
Figure 44 Italy: Market Overview, 2014 & 2020 (%)
Figure 45 Italy: Market, By Modality, 2015 & 2020 (USD Million)
Figure 46 Italy: Market, By Application, 2015 & 2020 (USD Million)
Figure 47 Spain: Market Overview, 2014 & 2020 (%)
Figure 48 Spain: Market, By Modality, 2015 & 2020 (USD Million)
Figure 49 Spain: Market, By Application, 2015 & 2020 (USD Million)
Figure 50 Switzerland: Market Overview, 2014 & 2020 (%)
Figure 51 Switzerland: Market, By Modality, 2015 & 2020 (USD Million)
Figure 52 Switzerland: Market, By Application, 2015 & 2020 (USD Million)
Figure 53 RoE: Market Overview, 2014 & 2020 (%)
Figure 54 RoE: Market, By Modality, 2015 & 2020 (USD Million)
Figure 55 RoE: Market, By Application, 2015 & 2020 (USD Million)
Figure 56 APAC: Market Overview, 2014 & 2020 (%)
Figure 57 APAC: Extracorporeal Membrane Oxygenation Systems Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 58 APAC: Extracorporeal Membrane Oxygenation Systems Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 59 APAC: Extracorporeal Membrane Oxygenation Systems Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 60 Japan: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 61 Japan: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 62 Japan: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 63 Australia: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 64 Australia: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 65 Australia: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 66 China: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 67 China: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 68 China: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 69 India: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 70 India: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 71 India: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 72 Singapore: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 73 Singapore: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 74 Singapore: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 75 Republic of Korea: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 76 Republic of Korea: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 77 Republic of Korea: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 78 Rest of APAC: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 79 Rest of APAC: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 80 Rest of APAC: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 81 RoW: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 82 RoW: Extracorporeal Membrane Oxygenation Systems Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 83 RoW: Extracorporeal Membrane Oxygenation Systems Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 84 RoW: Extracorporeal Membrane Oxygenation Systems Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 85 Extracorporeal Membrane Oxygenation System Market, By Company, 2014 (%)
Figure 86 Maquet Holding B.V. & Co. Kg.: Revenue Mix, 2014 (%)
Figure 87 Medtronic, Inc.: Revenue Mix, 2014 (%)
Figure 88 Microport Scientific Corporation: Revenue Mix, 2014 (%)
Figure 89 Terumo Corporation: Revenue Mix, 2014 (%)
Figure 90 Nipro Medical Corporation: Revenue Mix, 2014 (%)
Figure 91 Sorin Group: Revenue Mix, 2014 (%)